A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions
Clinical trial NCT03576469 · COMPLETED
Trial details
- NCT number
- NCT03576469
- Sponsor
- IMMUNOe Research Centers
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2019-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.